Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products,…
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its receipt of Health Canada approval, effective September 6, 2019, for the licensing of…
Biotechnology company and global drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced the successful completion of its master collaborative research agreement with the National Research Council of Canada (“NRC”) focused…
Data and artificial intelligence-driven discovery services company Predictive Oncology (NASDAQ: POAI) provides predictive models of tumor drug response to improve patient outcome. A recent article discussing the company reads, “Helomics applies artificial intelligence to its…
Increased number of registered BIGtoken users to 15.9 million in six months Invited to be a board member on the Interactive Advertising Bureau (IAB) Data Policy Board Deloitte Tech Fast 500 Winner Member of the…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced that it has received final approval to list its class A subordinated voting shares on the Toronto Stock Exchange…
The Green Organic Dutchman participated in the renowned Cannabis Investor Conference held by New West Partners TGOD received a 100 percent organic rating from Toronto-based Corporate Knightsmagazine The company endeavors to become a global leader in…
Lexaria Bioscience recently announced its DehydraTECH(TM) patent for pharmaceutical applications of cannabinoids to treat certain disease conditions Lexaria Bioscience’s patented DehydraTECH drug delivery platform can be used to deliver nicotine, cannabinoids and many other useful substances…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) on Tuesday issued an update regarding its clinical development programs, manufacturing and strategy for bringing its Oncoprex(TM) immunogene therapy to market. A corporate presentation is available on GNPX’s…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today commented on the recent transaction between Aurora Cannabis (TSX: ACB) and a syndicate of Canadian banks. Per the update, the…
Lexaria Bioscience is an innovator in the field of bioavailable lipophilic active compounds, and it is working to make consumption of certain products through oral ingestion a viable alternative to inhalation A particular focus of…
ETST reported $227,635 in revenue for the quarter ended June 30, 2019, marking a greater than 36 percent hike when compared to $166,891 for the same period in 2018 The company’s gross profits spiked by…
Helomics is collaborating with the University of Pittsburgh School of Medicine to study the use of artificial intelligence to improve clinical decision making for ovarian cancer patients. More than 22,000 women are diagnosed with ovarian…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced its receipt of Health Canada approval, under the Cannabis Regulations, to expand operations into its new Hamilton, Ontario-based hybrid…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games and toys in China, today announced that its CEO Xiaodong Chen rang the Nasdaq opening bell at…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered definitive agreements to acquire ABI SF, LLC. ABI SF operates a Bay Area cannabis…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, recently received coverage in a Bloomberg article discussing OGI’s financial results for the last four quarters (http://ibn.fm/BUMhB).…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, recently reported financial results for the second quarter ended June 30, 2019 (http://ibn.fm/shHin). An…
The Green Organic Dutchman is a cannabis-focused research and development company The company recently completed its inaugural shipment to the Ontario Cannabis Store, marking its entry into the recreational cannabis market TGOD continues to explore…
Organigram’s corporate governance distinguishes the company in the cannabis industry OGI’s consistent financial performance positions it as an “anomaly in the Canadian cannabis market” The company recently upgraded from the TSX Venture Exchange to the…